MR
EW icon

Munich Reinsurance’s Edwards Lifesciences EW Stock Holding History

Munich Reinsurance’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
1,407
-589
-30% -$49.3K ﹤0.01% 152
2026
Q1 		$160K Sell
1,996
-51,927
-96% -$4.28M ﹤0.01% 151
2025
Q4 		$4.65M Buy
53,923
+52,494
+3,673% +$4.31M 0.11% 103
2025
Q3 		$111K Buy
+1,429
New +$112K ﹤0.01% 188

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Munich Reinsurance's EW Position: Q2 2026 in Review

Munich Reinsurance reduced its Edwards Lifesciences (EW) stake by 30% in Q2 2026, selling an estimated $49.3K and leaving 1,407 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #152.

Munich Reinsurance first reported a position in EW in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.65M in Q4 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Munich Reinsurance held 1,407 shares of Edwards Lifesciences worth $127K as of Q2 2026.
  • Munich Reinsurance sold 589 Edwards Lifesciences shares in Q2 2026, an estimated $49.3K.
  • Edwards Lifesciences made up ﹤0.01% of Munich Reinsurance's portfolio in Q2 2026, its #152 holding.
  • Munich Reinsurance first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • Munich Reinsurance's Edwards Lifesciences position peaked at $4.65M in Q4 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Munich Reinsurance's 13F filing for Q2 2026, filed 24 Jul 2026.